Regeneron Pharmaceuticals (REGN)
Net Income
$1.95B
Quarterly · Period ending: · USD
REGN Net Income
Latest reported$1.95Bperiod ending
Latest reported$1.95Bperiod ending
REGN Quarterly Net Income (-$800.00K → $1.95B)
Quarterly net income
High-resolution chart · PNG
REGN net income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income (USD) |
|---|---|
| 1,948,700,000 | |
| 1,296,900,000 | |
| 727,200,000 | |
| 844,600,000 | |
| 1,460,000,000 | |
| 1,391,600,000 | |
| 808,700,000 | |
| 917,700,000 | |
| 1,340,600,000 | |
| 1,432,300,000 | |
| 722,000,000 | |
| 1,159,600,000 | |
| 1,007,800,000 | |
| 968,400,000 | |
| 817,800,000 | |
| 1,197,100,000 | |
| 1,315,700,000 | |
| 852,100,000 | |
| 973,500,000 | |
| 2,229,000,000 | |
| 1,632,200,000 | |
| 3,098,900,000 | |
| 1,115,200,000 | |
| 1,149,200,000 | |
| 842,100,000 | |
| 897,300,000 | |
| 624,600,000 | |
| 792,000,000 | |
| 669,600,000 | |
| 193,100,000 | |
| 461,100,000 | |
| 820,400,000 | |
| 594,655,000 | |
| 551,412,000 | |
| 477,980,000 | |
| 173,519,000 | |
| 388,317,000 | |
| 387,744,000 | |
| 248,931,000 | |
| 253,115,000 | |
| 264,804,000 | |
| 196,218,000 | |
| 165,736,000 | |
| 154,994,000 | |
| 210,398,000 | |
| 194,643,000 | |
| 76,021,000 | |
| 110,176,000 | |
| 79,720,000 | |
| 92,735,000 | |
| 65,443,000 | |
| 96,806,000 | |
| 141,306,000 | |
| 87,376,000 | |
| 98,874,000 | |
| 470,407,000 | |
| 191,468,000 | |
| 76,743,000 | |
| 11,651,000 | |
| -53,443,000 | |
| -62,365,000 | |
| -62,505,000 | |
| -43,447,000 | |
| -14,597,000 | |
| -33,875,000 | |
| -25,474,000 | |
| -30,522,000 | |
| -36,489,000 | |
| -1,015,000 | |
| -14,938,000 | |
| -17,481,000 | |
| -31,518,000 | |
| -21,115,000 | |
| -18,459,000 | |
| -11,618,000 | |
| -13,071,000 | |
| -35,838,000 | |
| -26,774,000 | |
| -29,917,000 | |
| -30,971,000 | |
| -27,410,000 | |
| -23,576,000 | |
| -20,380,000 | |
| -29,672,000 | |
| -34,652,000 | |
| -26,999,000 | |
| -4,123,000 | |
| 2,792,000 | |
| -11,076,000 | |
| -14,549,000 | |
| 64,532,000 | |
| -19,377,000 | |
| -27,400,000 | |
| -28,736,000 | |
| -30,110,000 | |
| -35,693,000 | |
| -32,816,000 | |
| -30,423,000 | |
| -25,445,000 | |
| -28,378,000 |